The Company's principal activities
The Company's principal activities consist in production and sale of products within protein research.
Insecurity regarding recognition or measurement
There is no material insecurity regarding recognition or measurement.
Exceptional circumstances
No exceptional circumstances have affected recognition or measurement.
Development in the activities and the financial situation of the Company
Development in activities and the financial situation
The Company's Income Statement of the financial year 1 July 2022 - 30 June 2023 shows a result of DKK -1.039.797 and the Balance Sheet at 30 June 2023 a balance sheet total of DKK 3.285.887 and an equity of DKK -175.156.
Post financial year events
After the end of the financial year, no events have occurred which may change the financial position of the entity substantially.
Development in activities and the financial situation
The Company's Income Statement of the financial year 1 July 2022 - 30 June 2023 shows a result of DKK -1.039.797 and the Balance Sheet at 30 June 2023 a balance sheet total of DKK 3.285.887 and an equity of DKK -175.156.
, Development in the activities and the financial situation of the Company
Development in activities and the financial situation
The Company's Income Statement of the financial year 1 July 2022 - 30 June 2023 shows a result of DKK -1.039.797 and the Balance Sheet at 30 June 2023 a balance sheet total of DKK 3.285.887 and an equity of DKK -175.156.
20-12-2023